UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy

ACS nano, 2017-11, Vol.11 (11), p.11127-11134

2017

Volltextzugriff (PDF)

Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus

Cell reports (Cambridge), 2018-04, Vol.23 (1), p.50-57

2018

Volltextzugriff (PDF)

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications

Scientific reports, 2015-10, Vol.5 (1), p.15400-15400, Article 15400

2015

Volltextzugriff (PDF)

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma

Haematologica (Roma), 2022-03, Vol.107 (10), p.2395-2407

2022

Volltextzugriff (PDF)

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes

Journal of Immunology, 2006-11, Vol.177 (9), p.6548-6559

2006

Volltextzugriff (PDF)

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor

Frontiers in immunology, 2017-09, Vol.8, p.1212-1212

2017

Volltextzugriff (PDF)

Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles

ACS omega, 2021-11, Vol.6 (43), p.28507-28514

2021

Volltextzugriff (PDF)

TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection

Nature (London), 2019-07, Vol.571 (7764), p.265-269

2019

Volltextzugriff (PDF)

Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T‑Cells in Vivo with Gold Nanoparticles and CT Imaging

ACS nano, 2015-06, Vol.9 (6), p.6363-6372

2015

Volltextzugriff (PDF)

Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide

Frontiers in medicine, 2021-08, Vol.8, p.675963-675963

2021

Volltextzugriff (PDF)

Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity

The Journal of immunology (1950), 2013-10, Vol.191 (8), p.4121-4129

2013

Volltextzugriff (PDF)

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

The Journal of clinical investigation, 2015-10, Vol.125 (10), p.3981-3991

2015

Volltextzugriff (PDF)

T-cells “à la CAR-T(e)” – Genetically engineering T-cell response against cancer

Advanced drug delivery reviews, 2019-02, Vol.141, p.23-40

2019

Volltextzugriff (PDF)

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells

The Journal of immunology (1950), 2012-02, Vol.188 (4), p.1708-1716

2012

Volltextzugriff (PDF)

Human gamma delta T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells

The Journal of immunology (1950), 2012-02, Vol.188 (4), p.1708-1716

2012

Volltextzugriff (PDF)

Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity

The Journal of immunology (1950), 2012-06, Vol.188 (11), p.5538-5546

2012

Volltextzugriff (PDF)

Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation

Nanomedicine, 2022-11, Vol.46, p.102596-102596, Article 102596

2022

Volltextzugriff (PDF)

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma

The Journal of clinical investigation, 2021-10, Vol.131 (20)

2021

Volltextzugriff (PDF)

Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System

Molecular therapy, 2016-06, Vol.24 (6), p.1078-1089

2016

Volltextzugriff (PDF)

Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells

Cancer immunology research, 2024-10, Vol.12 (10), p.1380-1391

2024

Volltextzugriff (PDF)

Selected murine residues endow human TCR with enhanced tumor recognition

The Journal of immunology (1950), 2010-06, Vol.184 (11), p.6232-6241

2010

Volltextzugriff (PDF)

How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer

Frontiers in immunology, 2012, Vol.3, p.186-186

2012

Volltextzugriff (PDF)

High Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA Electroporation

Molecular therapy, 2006-01, Vol.13 (1), p.151-159

2006

Volltextzugriff (PDF)

Adoptive T-cell Immunotherapy: Perfecting Self-Defenses

Experientia supplementum (2012), 2022, Vol.113, p.253-294

2022

Volltextzugriff (PDF)

Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma

Blood advances, 2024-08, Vol.8 (15), p.4077-4088

2024

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(42)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Humans
(25)
Life Sciences & Biomedicine
(23)
Animals
(14)
Mice
(13)
T-Lymphocytes - Immunology
(10)
Cell Line, Tumor
(9)
Immunology
(9)
Immunotherapy
(9)
Receptors, Antigen, T-Cell - Genetics
(8)
Antigens
(7)
Lymphocytes
(7)
Medicine, Research & Experimental
(7)
Research & Experimental Medicine
(7)
Melanoma
(6)
Cancer
(5)
Cells, Cultured
(5)
Female
(5)
Gene Therapy
(5)
Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy

Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor

Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles

TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection

Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T‑Cells in Vivo with Gold Nanoparticles and CT Imaging

Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide

Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

T-cells “à la CAR-T(e)” – Genetically engineering T-cell response against cancer

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells

Human gamma delta T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells

Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity

Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma

Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System

Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells

Selected murine residues endow human TCR with enhanced tumor recognition

How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer

High Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA Electroporation

Adoptive T-cell Immunotherapy: Perfecting Self-Defenses

Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma

Aktive Filter

Suchergebnisse filtern